A 39−year−old white man presented with a 2−year history of intermittant, sharp, left−sided chest pain. Two years before, the patient had had an injection of nonre− sorbable co−polymer (Enteryx; Boston Scientific Corp., Natick, Massachusetts, USA) into the lower esophageal sphincter as a treatment for refractory gastroesoph− ageal reflux disease, and had tolerated the procedure satisfactorily except for mild postprocedural chest pain. Concerned about an Enteryx−related complication, we ordered a chest radio− graph, upper endoscopy, an upper gastro− intestinal series, pH−metry and manome− try, which were all normal. As we expect− ed, a noncontrast computed tomographic scan of the chest, abdomen, and pelvis re− vealed polymer around the gastroesopha− geal junction (l " Fig. 1 ). Unexpectedly, hyperdense material was also seen in the subcarinal region (l " Fig. 2 ) and the right hilum (l " Fig. 3 ), consistent with polymer migration. In addition, polymer seemed to have migrated to the liver (see l " Fig. 1 ), the spleen, and the wall of the small intestine (l " Fig. 4 ). The United States' Food and Drug Admin− istration recalled Enteryx as a result of its association with significant complica− tions, including esophageal abscesses, stenosis, polymer migration, and death [1 ± 4] . Although our patient has evidence of polymer migration to several anatomi− cal sites, this is unlikely to be responsible for his current symptoms. This migration probably occurred at the time of his pro− cedure as a result of inadvertant trans− mural injection of polymer into blood vessels or lymphatics. The best explana− tion of our patient's current symptoms is a hypersensitive or irritable esophagus secondary to his Enteryx procedure. Enteryx polymer migration to lymph nodes and beyond Fig. 1 As expected, computed tomography revealed hyperdense material, consistent in appearance with polymer, around the gastro− esophageal junction. A 0.6−cm focus was also seen in the left lower lobe of the liver. 
